<?xml version="1.0" encoding="UTF-8"?>
<rootTag>
<Award>
<AwardTitle>EAPSI:  Glycosaminoglycans in the Aortic Valve: the Role of Distribution and Orientation on Biomechanics</AwardTitle>
<AGENCY>NSF</AGENCY>
<AwardEffectiveDate>06/01/2010</AwardEffectiveDate>
<AwardExpirationDate>05/31/2011</AwardExpirationDate>
<AwardTotalIntnAmount>5617.00</AwardTotalIntnAmount>
<AwardAmount>5617</AwardAmount>
<AwardInstrument>
<Value>Fellowship Award</Value>
</AwardInstrument>
<Organization>
<Code>01090000</Code>
<Directorate>
<Abbreviation>O/D</Abbreviation>
<LongName>Office Of The Director</LongName>
</Directorate>
<Division>
<Abbreviation>OISE</Abbreviation>
<LongName>Office Of Internatl Science &amp;Engineering</LongName>
</Division>
</Organization>
<ProgramOfficer>
<SignBlockName>Anne Emig</SignBlockName>
<PO_EMAI>aemig@nsf.gov</PO_EMAI>
<PO_PHON>7032927241</PO_PHON>
</ProgramOfficer>
<AbstractNarration/>
<MinAmdLetterDate>06/07/2010</MinAmdLetterDate>
<MaxAmdLetterDate>06/07/2010</MaxAmdLetterDate>
<ARRAAmount/>
<TRAN_TYPE>Grant</TRAN_TYPE>
<CFDA_NUM>47.079</CFDA_NUM>
<NSF_PAR_USE_FLAG>0</NSF_PAR_USE_FLAG>
<FUND_AGCY_CODE>4900</FUND_AGCY_CODE>
<AWDG_AGCY_CODE>4900</AWDG_AGCY_CODE>
<AwardID>1015590</AwardID>
<Investigator>
<FirstName>Brandon</FirstName>
<LastName>Mikulis</LastName>
<PI_MID_INIT>T</PI_MID_INIT>
<PI_SUFX_NAME/>
<PI_FULL_NAME>Brandon T Mikulis</PI_FULL_NAME>
<EmailAddress/>
<PI_PHON>5857496020</PI_PHON>
<NSF_ID>000553147</NSF_ID>
<StartDate>06/07/2010</StartDate>
<EndDate/>
<RoleCode>Principal Investigator</RoleCode>
</Investigator>
<Institution>
<Name>Mikulis                 Brandon        T</Name>
<CityName>Pittsburgh</CityName>
<ZipCode>152063440</ZipCode>
<PhoneNumber/>
<StreetAddress/>
<StreetAddress2/>
<CountryName>United States</CountryName>
<StateName>Pennsylvania</StateName>
<StateCode>PA</StateCode>
<CONGRESSDISTRICT>18</CONGRESSDISTRICT>
<CONGRESS_DISTRICT_ORG>PA18</CONGRESS_DISTRICT_ORG>
<ORG_DUNS_NUM/>
<ORG_LGL_BUS_NAME/>
<ORG_PRNT_DUNS_NUM/>
</Institution>
<Performance_Institution>
<Name><![CDATA[Mikulis                 Brandon        T]]></Name>
<CityName>Pittsburgh</CityName>
<StateCode>PA</StateCode>
<ZipCode>152063440</ZipCode>
<StreetAddress/>
<CountryCode>US</CountryCode>
<CountryName>United States</CountryName>
<StateName>Pennsylvania</StateName>
<CountryFlag>1</CountryFlag>
<CONGRESSDISTRICT>18</CONGRESSDISTRICT>
<CONGRESS_DISTRICT_PERF>PA18</CONGRESS_DISTRICT_PERF>
</Performance_Institution>
<ProgramElement>
<Code>7316</Code>
<Text>EAPSI</Text>
</ProgramElement>
<ProgramReference>
<Code>5941</Code>
<Text>NEW ZEALAND</Text>
</ProgramReference>
<ProgramReference>
<Code>5978</Code>
<Text>EAST ASIA AND PACIFIC PROGRAM</Text>
</ProgramReference>
<ProgramReference>
<Code>7316</Code>
<Text>EAPSI</Text>
</ProgramReference>
<Appropriation>
<Code>0110</Code>
<Name>NSF RESEARCH &amp; RELATED ACTIVIT</Name>
<APP_SYMB_ID>040100</APP_SYMB_ID>
</Appropriation>
<FUND_OBLG>2010~5617</FUND_OBLG>
<POR>
<DRECONTENT><![CDATA[<div class="porColContainerWBG"> <div class="porContentCol"><p>&nbsp; &nbsp; &nbsp;Given the limited number of human heart valves available for heart valve replacement surgeries, chemically treated heart valves from other animals are becoming a more common option for these surgeries.&nbsp; This chemical treatment process is necessary to enable implantation into a human, but also alters the underlying structure of the heart valve tissue and may play a role in the limited lifespan of these valves. This award was utilized to develop a new imaging technique for the investigation of how the chemical treatment alters the structure of heart valve tissue. Current research to improve the longevity of these chemically treated replacement heart valves will benefit from the developed imaging technique.</p> <p>&nbsp; &nbsp; &nbsp;A one of a kind microscope, developed for imaging the 3D structure of tissues, was employed to carry out the research. Previous work identified tissue components that are believed to contribute to the structural failure of chemically treated heart valves. During the course of this award the appropriate tissue preparation and staining protocols were developed to visualize these tissue components using the microscope. Additionally, suitable imaging parameters were established to enable measurements of the structural changes induced by the chemical treatment process. Image processing algorithms were then developed to provide quantitative measures of the distribution of tissue components under investigation.</p> <p>&nbsp; &nbsp; &nbsp;&nbsp;Using the developed imaging protocol, including the staining and image processing, 3D data will be collected on both chemically treated and non-treated heart valves. This data will be collected on valves that are new as well has valves that have undergone accelerated wear testing in a laboratory. The results of the imaging studies will be compared to mechanical testing performed on samples of valve tissue that has been through the same process. This relationships seen between the changes as measured by imaging and the changes in mechanical properties will help researchers understand how the chemical treatment process affects the valves and will help them determine what changes need to be made to improve longevity.</p> <p>&nbsp;</p><br> <p>            Last Modified: 12/06/2011<br>      Modified by: Brandon&nbsp;T&nbsp;Mikulis</p> </div> <div class="porSideCol"></div> </div>]]></DRECONTENT>
<POR_COPY_TXT><![CDATA[      Given the limited number of human heart valves available for heart valve replacement surgeries, chemically treated heart valves from other animals are becoming a more common option for these surgeries.  This chemical treatment process is necessary to enable implantation into a human, but also alters the underlying structure of the heart valve tissue and may play a role in the limited lifespan of these valves. This award was utilized to develop a new imaging technique for the investigation of how the chemical treatment alters the structure of heart valve tissue. Current research to improve the longevity of these chemically treated replacement heart valves will benefit from the developed imaging technique.       A one of a kind microscope, developed for imaging the 3D structure of tissues, was employed to carry out the research. Previous work identified tissue components that are believed to contribute to the structural failure of chemically treated heart valves. During the course of this award the appropriate tissue preparation and staining protocols were developed to visualize these tissue components using the microscope. Additionally, suitable imaging parameters were established to enable measurements of the structural changes induced by the chemical treatment process. Image processing algorithms were then developed to provide quantitative measures of the distribution of tissue components under investigation.        Using the developed imaging protocol, including the staining and image processing, 3D data will be collected on both chemically treated and non-treated heart valves. This data will be collected on valves that are new as well has valves that have undergone accelerated wear testing in a laboratory. The results of the imaging studies will be compared to mechanical testing performed on samples of valve tissue that has been through the same process. This relationships seen between the changes as measured by imaging and the changes in mechanical properties will help researchers understand how the chemical treatment process affects the valves and will help them determine what changes need to be made to improve longevity.          Last Modified: 12/06/2011       Submitted by: Brandon T Mikulis]]></POR_COPY_TXT>
</POR>
</Award>
</rootTag>
